Linfomas
Dr. Mariano Provencio
Dra Blanca Cantos
Dra Virginia Calvo
PRODUCCIÓN CIENTÍFICA sobre linfomas
PUBLICACIONES
2013
- New drugs and targeted treatments in Hodgkin's lymphoma.
- Provencio M, Sánchez A, Sánchez-Beato M.
- Cancer Treat Rev. 2013 Sep 20. doi:pii: S0305-7372(13)00194-1. 10.1016/j.ctrv.2013.09.005.
- High serum levels of VEGF-C have a positive impact on outcome of advanced diffuse large B cell lymphoma patients. Rueda A, Rifá J, Quero C, Gómez-Codina J, Murias A, García-Arroyo FR, Sabín P, Llanos M, Herrero J, Lobo F, Delgado JR, Provencio M; on behalf of the Spanish Lymphoma Oncology Group. Leuk Lymphoma. 2013 Aug 22.
- Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicularlymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group. Provencio M, Cruz Mora MA, Gómez-Codina J, Quero Blanco C, Llanos M, García-Arroyo FR, de la Cruz L, Gumá Padró J, Delgado Pérez JR, Sánchez A, Alvarez Cabellos R, Rueda A; for the Gotel (Spanish Lymphoma Oncology Group). Leuk Lymphoma. 2013 Jun 12. [Epub ahead of print]
2012
- Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain? Provencio M, Sabín P, Gómez Codina J, Rueda A, Llanos M, Gumá J, Quero Blanco C, Blasco A, Delgado JR, Cruz MÁ, Aguiar D, García-Arroyo FR, Herrero J, Lavernia J, Martínez Banaclocha N, Morales M, Fuster J, Sáez Cusi Á, Lobo F, Rodríguez Abreu D, de la Cruz L, Antón E, Rodríguez Jiménez A, Arízcun A, Pérez X; GOTEL (Spanish Lymphoma Oncology Group). Clin Transl Oncol. 2012 May;14(5):386-90.
- Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish HodgkinLymphoma Study Group series. Guisado-Vasco P, Arranz-Saez R, Canales M, Cánovas A, Garcia-Laraña J, García-Sanz R, Lopez A, López JL, Llanos M, Moraleda JM, Rodriguez J, Rayón C, Sabin P, Salar A, Marín-Niebla A, Morente M, Sánchez-Godoy P, Tomás JF, Muriel A, Abraira V, Piris MA, Garcia JF, Montalban C; Spanish Hodgkin Lymphoma Study Group. Leuk Lymphoma. 2012 May;53(5):812-9. doi: 10.3109/10428194.2011.635861. Epub 2012 Jan 31.
2011
- Clinical practice guidelines for first-line/after-relapse treatment of patients with follicularlymphoma. López-Guillermo A, Caballero D, Canales M, Provencio M, Rueda A, Salar A; Spanish Hematology and Hemotherapy Association; Oncological Group for the Treatment of Lymphatic Diseases; Spanish Lymphomas/Autologous Bone Marrow Transplant Group. Leuk Lymphoma. 2011 Dec;52 Suppl 3:1-14. doi: 10.3109/10428194.2011.629897.
- Epstein-Barr virus in the germinal centres of adenopathies affected by classic Hodgkinlymphoma. Martín P, Gomez-Lozano N, Montes S, Salas C, Provencio M, Bellas C. Histopathology. 2011 Aug;59(2):349-52. doi: 10.1111/j.1365-2559.2011.03904.x. No abstract available.
- Heterogeneous expression of Src tyrosine kinases Lyn, Fyn and Syk in classical Hodgkinlymphoma: prognostic implications. Martín P, Salas C, Provencio M, Abraira V, Bellas C. Leuk Lymphoma. 2011 Nov;52(11):2162-8. doi: 10.3109/10428194.2011.594926. Epub 2011 Jul 13.
- Breast cancer occurred after Hodgkin's disease: clinico-pathological features, treatments and outcome: analysis of 214 cases. Cutuli B, Kanoun S, Tunon De Lara C, Baron M, Livi L, Levy C, Cohen-Solal-Lenir C, Lesur A, Kerbrat P, Provencio M, Gonzague-Casabianca L, Mege A, Lemanski C, Delva C, Lancrenon S, Velten M. Crit Rev Oncol Hematol. 2012 Jan;81(1):29-37. doi: 10.1016/j.critrevonc.2011.01.005. Epub 2011 Feb 17.
2010
- Central nervous system involvement in Hodgkin's lymphoma. Galán L, Sánchez AC, Cantos B, Provencio M. Med Oncol. 2011 Dec;28 Suppl 1:S505-8. doi: 10.1007/s12032-010-9692-z. Epub 2010 Oct 14.
- Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era. Provencio M, Martín P, García V, Candia A, Sánchez AC, Bellas C. Leuk Lymphoma. 2010 Nov;51(11):2021-30. doi: 10.3109/10428194.2010.516039. Epub 2010 Oct 4.
- Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes. Alvaro T, de la Cruz-Merino L, Henao-Carrasco F, Villar Rodríguez JL, Vicente Baz D, Codes Manuel de Villena M, Provencio M. J Biomed Biotechnol. 2010;2010. doi:pii: 846872. 10.1155/2010/846872. Epub 2010 Aug 12. Review.
- SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma. Rodríguez-Abreu D, Llanos Muñoz M, Provencio Pulla M, Rueda Domínguez A, Isla Casado D; SEOM (Spanish Society for Medical Oncology). Clin Transl Oncol. 2010 Nov;12(11):760-4.
- SEOM clinical guidelines for the treatment of Hodgkin's lymphoma. Quero Blanco C, García Arroyo R, Provencio Pulla M, Rueda Domínguez A, Isla Casado D; SEOM (Spanish Society for Medical Oncology). Clin Transl Oncol. 2010 Nov;12(11):753-9.
- Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab. Maximiano Alonso C, Sánchez Ruiz AC, Cantos Sánchez de Ibargüen B, Méndez García M, Ronco IS, Provencio Pulla M. Clin Transl Oncol. 2010 Oct;12(10):701-3.
- Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study. Provencio M, Salas C, Millán I, Cantos B, Sánchez A, Bellas C. Leuk Lymphoma. 2010 Sep;51(9):1686-91. doi: 10.3109/10428194.2010.500432
- Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era. Sancho JM, Orfao A, Quijano S, García O, Panizo C, Pérez-Ceballos E, Deben G, Salar A, González-Barca E, Alonso N, García-Vela JA, Capote J, Peñalver FJ, Provencio M, Arias J, Plaza J, Caballero D, Morado M, Feliu E, Ribera JM; Spanish Group for the Study of CNS Disease in NHL. Eur J Haematol. 2010 Oct;85(4):321-8. doi: 10.1111/j.1600-0609.2010.01478.x. Epub 2010 Jul 28.
2009
- Rituximab monotherapy in relapsed lymphocyte-predominant Hodgkin's lymphoma. Galán L, Sánchez AC, Cantos B, Provencio M. Clin Transl Oncol. 2010 May;12(5):384-6. doi: 10.1007/s12094-010-0521-9.
- Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications. Garcia V, Garcia JM, Silva J, Martin P, Peña C, Dominguez G, Diaz R, Herrera M, Maximiano C, Sabin P, Rueda A, Cruz MA, Rodriguez J, Canales MA, Bonilla F, Provencio M. PLoS One. 2009 Dec 15;4(12):e8173. doi: 10.1371/journal.pone.0008173.
- A prospective study of left ventricle function after treatment with rapid-infusion rituximab in patients with non-Hodgkin lymphoma. Provencio M, Sanchez A, Maximiano C, Cantos B, Méndez M, Bonilla F. Leuk Lymphoma. 2009 Oct;50(10):1642-6. doi: 10.1080/10428190903186478.
- Differential genetic and functional markers of second neoplasias in Hodgkin's disease patients. Lorenzo Y, Provencio M, Lombardía L, Díaz R, Silva J, Herrera M, García JM, Peña C, García V, Romero J, Domínguez G, Bonilla F. Clin Cancer Res. 2009 Aug 1;15(15):4823-8. doi: 10.1158/1078-0432.CCR-08-3224. Epub 2009 Jul 21.
- Clinical-molecular factors predicting response and survival for tyrosine-kinase inhibitors. Provencio M, García-Campelo R, Isla D, de Castro J. Clin Transl Oncol. 2009 Jul;11(7):428-36. Review.
- A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples. Sánchez-Espiridión B, Sánchez-Aguilera A, Montalbán C, Martin C, Martinez R, González-Carrero J, Poderos C, Bellas C, Fresno MF, Morante C, Mestre MJ, Mendez M, Mazorra F, Conde E, Castaño A, Sánchez-Godoy P, Tomas JF, Morente MM, Piris MA, García JF; Spanish Hodgkin'sLymphoma Study Group. Clin Cancer Res. 2009 Feb 15;15(4):1367-75. doi: 10.1158/1078-0432.CCR-08-1119.
- Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.Quijano S, López A, Manuel Sancho J, Panizo C, Debén G, Castilla C, Antonio García-Vela J, Salar A, Alonso-Vence N, González-Barca E, Peñalver FJ, Plaza-Villa J, Morado M, García-Marco J, Arias J, Briones J, Ferrer S, Capote J, Nicolás C, Orfao A; Spanish Group for the Study of CNS Disease in NHL. J Clin Oncol. 2009 Mar 20;27(9):1462-9. doi: 10.1200/JCO.2008.17.7089. Epub 2009 Feb 17.
2008
- Analysis of competing risks of causes of death and their variation over different time periods in Hodgkin's disease.nProvencio M, Millán I, España P, Sánchez AC, Sánchez JJ, Cantos B, Vargas JA, Bellas C, García V, Sabin P, Bonilla F. Clin Cancer Res. 2008 Aug 15;14(16):5300-5. doi: 10.1158/1078-0432.CCR-07-0927.
- Hodgkin's disease and intercurrent processes that may simulate a relapse. Sánchez A, Cantos B, España P, Salas C, Provencio M. Clin Transl Oncol. 2008 Jul;10(7):439-41.
- [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma]. Provencio M, Fayad LE. Med Clin (Barc). 2008 Jan 26;130(2):60-5. Review. Spanish. No abstract available.
- R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: a multicentre, prospective study. Rueda A, Sabin P, Rifá J, Llanos M, Gómez-Codina J, Lobo F, García R, Herrero J, Provencio M, Jara C; Grupo Oncológico para el Tratamiento y Estudio de los Linfomas (GOTEL). Hematol Oncol. 2008 Mar;26(1):27-32.
2006
- Association between hepatitis C virus and non-Hodgkin's lymphomas. Provencio M, Sánchez A, Bonilla F, España P. J Clin Oncol. 2006 Jul 20;24(21):3513; author reply 3513-4. No abstract available.
- Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Sánchez-Aguilera A, Montalbán C, de la Cueva P, Sánchez-Verde L, Morente MM, García-Cosío M, García-Laraña J, Bellas C, Provencio M, Romagosa V, de Sevilla AF, Menárguez J, Sabín P, Mestre MJ, Méndez M, Fresno MF, Nicolás C, Piris MA, García JF; Spanish Hodgkin LymphomaStudy Group.Blood. 2006 Jul 15;108(2):662-8. Epub 2006 Mar 21.
- Rapid-infusion rituximab in lymphoma treatment. Provencio M, Cerdeira S, Bonilla F, Sánchez A, España P. Ann Oncol. 2006 Jun;17(6):1027-8. Epub 2005 Dec 1. No abstract available.
- Prognostic factors in Hodgkin's disease. Provencio M, España P, Millán I, Yebra M, Sánchez AC, de la Torre A, Bonilla F, Regueiro CA, de Letona JM. Leuk Lymphoma. 2004 Jun;45(6):1133-9.
2004
2003
- The management of stage I-II supradiaphragmatic Hodgkin's disease with chemotherapy alone. Provencio M, España P, Millán I, Sánchez A, Cantos B, Bonilla F. Leuk Lymphoma. 2003 Feb;44(2):263-8.
- The topoisomerase IIalpha expression correlates with survival in patients with advanced Hodgkin's lymphoma. Provencio M, Corbacho C, Salas C, Millan I, Espana P, Bonilla F, Ramon Cajal S. Clin Cancer Res. 2003 Apr;9(4):1406-11.
- Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U, Klasa R, Ozsahin M, Mead GM, Gianni MA, Cortelazzo S, Ferreri AJ, Ambrosetti A, Martelli M, Thiéblemont C, Moreno HG, Pinotti G, Martinelli G, Mozzana R, Grisanti S, Provencio M, Balzarotti M, Laveder F, Oltean G, Callea V, Roy P, Cavalli F, Gospodarowicz MK; International Extranodal Lymphoma Study Group. J Clin Oncol. 2003 Jan 1;21(1):20-7.
2001
- Hodgkin's disease: unsuspected minimal activity in patients that die from causes other than tumoral progression. Provencio M, España P, Salas C, Sánchez A, Bonilla F. Leuk Lymphoma. 2001 Aug;42(4):66
- Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Cutuli B, Borel C, Dhermain F, Magrini SM, Wasserman TH, Bogart JA, Provencio M, de Lafontan B, de la Rochefordiere A, Cellai E, Graic Y, Kerbrat P, Alzieu C, Teissier E, Dilhuydy JM, Mignotte H, Velten M. Radiother Oncol. 2001 Jun;59(3):247-55.
2000
- Hodgkin's disease: correlation between causes of death at autopsy and clinical diagnosis. Provencio M, España P, Salas C, Navarro F, Bonilla F. Ann Oncol. 2000 Jan;11(1):59-64.
- 1999
- Comparison of the long-term mortality in Hodgkin's disease patients with that of the general population. Provencio M, García-López FJ, Bonilla F, España P. Ann Oncol. 1999 Oct;10(10):1199-205.
- [Cardiotoxicity and intensification chemotherapy]. Llamas P, Provencio M, Rubio A, Cabrera R, Fernández MN. Sangre (Barc). 1995 Feb;40(1):76. Spanish. No abstract available.
LIBROS
- Perspectivas futuras y terapias experimentales en la enfermedad de Hodgkin. Provencio M, España P, Bonilla F. En libro: Linfoma de Hodgkin: aproximación diagnóstica y terapéutica. 2006. pp 159-167. Aula Ediciones. ISBN: 84-7885-414-2
- Highlignts del 6º Simposio Internacional sobre Linfoma de Hodgkin: 25 años de experiencia del Grupo Alemán. Canales M, Provencio M. En libro: Linfoma de Hodgkin: aproximación diagnóstica y terapéutica. 2006. pp169-175. Grupo Aula Ediciones. ISBN: 84-7885-414-2
- Editor del libro: Linfoma de Hodgkin: aproximación diagnóstica y terapéutica. 2006. Grupo Aula Ediciones. ISBN: 84-7885-414-2.
- Consenso sobre el uso de agentes eritropoyéticos en pacientes anémicos con cáncer. SEOM. Uso de los agentes eritropoyéticos en la anemia inducida por quimioterapia. Nivel de hemoglobina al inicio del tratamiento. Objetivo final de hemoglobina. Provencio M. pp 31-37. Prodrug Multimedia. SL. 2007. ISBN: 978-84-95972-43-9.
- Linfoma. Provencio M. En: “Novedades en la literatura Oncológica” 2007. ISBN: 978-84-612-2528-6. 2008.
- ¿Qué es el Linfoma de Hodgkin? M Provencio. 2008. Colección AEAL Explica.
- Linfomas T. Provencio M, Sánchez AC. Colección AEAL Explica. 2009
- Guía Práctica Clínica para el tratamiento de pacientes con linfoma folicular en primera línea y tras la recaída. A. López-Guillermo, A Salar, A Rueda, D Caballero, M Provencio, M Canales. 2011
- Linfomas B y T. Biología, clínica y tratamiento. Editores: Mariano Provencio y Miguel Ángel Canales. Tercera Edición. AulaMédica. ISBN-13: 978-84-7885-541-4. 2012.
- Capítulo de libro: Linfoma difuso de células grandes, 285-299. M Provencio, A López Guillermo. En: Linfomas B y T. Biología, clínica y tratamiento. Tercera Edición. AulaMédica. ISBN-13: 978-84-7885-541-4. 2012.
- Linfomas de alto grado. Linfoma Linfoblástico, 365-376. M Méndez, A Custodio, M Provencio. En: En: Linfomas B y T. Biología, clínica y tratamiento. Tercera Edición. AulaMédica. ISBN-13: 978-84-7885-541-4. 2012.
- Editor libro: Oncología para estudiantes de Medicina. 2012. Ediciones Arán. ISBN: 978-84-92977-31-4
- Common treatments for lymphoma.En: Lymphomas. Essentials for clinicians. Editors: Michele Ghielmini, Silvia Montoto. Pag 25-37. ESMO 2012. ISBN: 978-88-906359-2-2.
ENSAYOS CLÍNICOS